Digitek and Legal Compensation
Digitek®, also known as digoxin, is prescribed to treat heart failure and irregular heartbeat (arrhythmia). The manufacturer of Digitek / digoxin tablets is recalling the product, saying that it may have accidentally released pills that are double the normal thickness, thus carrying twice the active ingredient. On April 28, 2008, drug manufacturers Actavis Totowa LLC issued a Class I nationwide recall of all Digitek® digoxin tablets distributed between March 2006 and April 2008. The pills may contain two times the acceptable dosage of the active ingredient. On August 13, 2008, the federal Judicial Panel on Multidistrict Litigation (JPMDL) approved creation of a Digitek® products liability multidistrict litigation in the U.S. District Court for the Southern District of West Virginia. Thus, all pending and future Digitek® lawsuits filed in the federal court system will be centralized for discovery purposes.
The manufacturer of Digitek® / digoxin tablets recalled the product, saying that it may have accidentally released pills that were double the normal thickness, thus carrying twice the active ingredient.
Class I recalls are conducted when dangerous or defective products that predictably could cause serious health problems or death are released. Digitek® is distributed by Mylan Pharmaceuticals under a Bertek label and by UDL Laboratories under a UDL label. According to a press release from Digitek’s manufacturer, Actavis, digitalis toxicity “can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia,” and even death.
Patients should expect to receive safe prescription drugs. If you or someone you know has had a severe reaction due to the use of recalled Digitek® or digoxin tablets, you may have a product defect claim.